Phargomed El Salvador
WhatsApp
Strem Chemicals

Catálogo Strem Chemicals

6,537 productos · busca por nombre, modelo o número de parte

6,537 resultados
Producto
4-[Polyisobutyl(12)]-2-ethylaniline (50% in heptane/polyisobutylene)4-[Polyisobutyl(12)]-2-ethylaniline (50% in heptane/polyisobutylene)Ver →
4-[Polyisobutyl(18)]-2,6-(di-i-propyl)aniline (50% in heptane/polyisobutylene)4-[Polyisobutyl(18)]-2,6-(di-i-propyl)aniline (50% in heptane/polyisobutylene)Ver →
4-[Polyisobutyl(18)]-2-(t-butyl)phenol (50% in heptane/polyisobutylene)4-[Polyisobutyl(18)]-2-(t-butyl)phenol (50% in heptane/polyisobutylene)Ver →
4-[Polyisobutyl(18)]phenol (50% in heptane/polyisobutylene)4-[Polyisobutyl(18)]phenol (50% in heptane/polyisobutylene)Ver →
4-Prop-2-ynyl-piperidine-1-carboxylic acid benzyl ester, 95%4-Prop-2-ynyl-piperidine-1-carboxylic acid benzyl ester, 95%Ver →
4-Propoxybenzoic acid, min. 99%4-Propoxybenzoic acid, min. 99%Ver →
4-(Pyridin-4-yl)-1H-indole, 95%4-(Pyridin-4-yl)-1H-indole, 95%Ver →
4-(Pyrimidin-5-yl)-1H-indole, 95%4-(Pyrimidin-5-yl)-1H-indole, 95%Ver →
(4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-isopropyloxazole], 98%, (99% ee)(4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-isopropyloxazole], 98%, (99% ee)Ver →
(4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-tert-butyloxazole], 98%, (99% ee)(4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-tert-butyloxazole], 98%, (99% ee)Ver →
(4R,4'R)-2,2'-[2-Phenyl-1-(phenylmethyl)ethylidene]bis[4-(1-methylethyl)-4,5-dihydrooxazole], min. 98%(4R,4'R)-2,2'-[2-Phenyl-1-(phenylmethyl)ethylidene]bis[4-(1-methylethyl)-4,5-dihydrooxazole], min. 98%Ver →
(4R,4'R)-2,2'-(Cycloheptane-1,1-diyl)bis(4-tert-butyl-4,5-dihydrooxazole), 98%, (99% ee)(4R,4'R)-2,2'-(Cycloheptane-1,1-diyl)bis(4-tert-butyl-4,5-dihydrooxazole), 98%, (99% ee)Ver →
(4R,4'R)-2,2'-Cyclohexylidenebis[4,5-dihydro-4-phenyloxazole], 95%, (98% ee)(4R,4'R)-2,2'-Cyclohexylidenebis[4,5-dihydro-4-phenyloxazole], 95%, (98% ee)Ver →
(4R,4'R)-2,2'-Cyclohexylidenebis[4-tert-butyl-4,5-dihydrooxazole], 98%, (99% ee)(4R,4'R)-2,2'-Cyclohexylidenebis[4-tert-butyl-4,5-dihydrooxazole], 98%, (99% ee)Ver →
(4R,4'R)-2,2'-Cyclopentylidenebis[4,5-dihydro-4-phenyloxazole], 95% (99% ee)(4R,4'R)-2,2'-Cyclopentylidenebis[4,5-dihydro-4-phenyloxazole], 95% (99% ee)Ver →
(4R,4'R,5S,5'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4,5-diphenyloxazole], 98%(4R,4'R,5S,5'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4,5-diphenyloxazole], 98%Ver →
(4R,4'R,5S,5'S)-2,2'-Cyclobutylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%(4R,4'R,5S,5'S)-2,2'-Cyclobutylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%Ver →
(4R,4'R,5S,5'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole), 98%, (99% ee)(4R,4'R,5S,5'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole), 98%, (99% ee)Ver →
(4R,4'R,5S,5'S)-2,2'-Cyclohexylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%, (99% ee)(4R,4'R,5S,5'S)-2,2'-Cyclohexylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%, (99% ee)Ver →
(4R,4'R,5S,5'S)-2,2'-Cyclopentylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%, (99% ee)(4R,4'R,5S,5'S)-2,2'-Cyclopentylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%, (99% ee)Ver →
(4R,4'R,5S,5'S)-2,2'-Cyclopropylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%, (99% ee)(4R,4'R,5S,5'S)-2,2'-Cyclopropylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%, (99% ee)Ver →
(4R,5R)-N-(3,5-Bis(trifluoromethyl)phenyl)-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-amine, 98%, (99% ee)(4R,5R)-N-(3,5-Bis(trifluoromethyl)phenyl)-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-amine, 98%, (99% ee)Ver →
((4R,5R)-(+)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl] (dicyclohexylphosphinite)(1,5-COD)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenylborate, min. 97% (R,R)-[COD]Ir[cy₂PThrePHOX]((4R,5R)-(+)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl] (dicyclohexylphosphinite)(1,5-COD)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenylborate, min. 97% (R,R)-[COD]Ir[cy₂PThrePHOX]Ver →
((4R,5R)-(+)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl] (diphenylphosphinite)(1,5-COD)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenylborate, min. 97% (R,R)-[COD]Ir[Ph₂PThrePHOX]((4R,5R)-(+)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl] (diphenylphosphinite)(1,5-COD)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenylborate, min. 97% (R,R)-[COD]Ir[Ph₂PThrePHOX]Ver →
(4R,5R)-(-)-O-Isopropylidene-2,3-dihydroxy-1,4-bis(p-tosyl)butane(4R,5R)-(-)-O-Isopropylidene-2,3-dihydroxy-1,4-bis(p-tosyl)butaneVer →
(4R,5S)-(+)-4-Benzyl-5-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-2-oxazolidinone, 99%(4R,5S)-(+)-4-Benzyl-5-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-2-oxazolidinone, 99%Ver →
(4R,5S)-(+)-4-i-Propyl-5-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-2-oxazolidinone, 99%(4R,5S)-(+)-4-i-Propyl-5-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-2-oxazolidinone, 99%Ver →
(4S,4'S)-2,2'-(1,3-Bis[4-(t-butyl)phenyl)propane-2,2-diyl]bis(4-phenyl-4,5-dihydrooxazole) (S)-BTBBPh-SaBOX(4S,4'S)-2,2'-(1,3-Bis[4-(t-butyl)phenyl)propane-2,2-diyl]bis(4-phenyl-4,5-dihydrooxazole) (S)-BTBBPh-SaBOXVer →
(4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-isopropyloxazole], 98%, (99% ee)(4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-isopropyloxazole], 98%, (99% ee)Ver →
(4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-tert-butyloxazole], 98%(4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-tert-butyloxazole], 98%Ver →
(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole) (S)-BnPh-SaBOX(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole) (S)-BnPh-SaBOXVer →
(4S,4'S)-2,2'-[2-Phenyl-1-(phenylmethyl)ethylidene]bis[4-(1-methylethyl)-4,5-dihydrooxazole], 95%, (99% ee)(4S,4'S)-2,2'-[2-Phenyl-1-(phenylmethyl)ethylidene]bis[4-(1-methylethyl)-4,5-dihydrooxazole], 95%, (99% ee)Ver →
(4S,4'S)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-isopropyloxazole], min. 98%(4S,4'S)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-isopropyloxazole], min. 98%Ver →
(4S,4'S)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-phenyloxazole], 98%(4S,4'S)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-phenyloxazole], 98%Ver →
(4S,4'S)-2,2'-Cyclobutylidenebis[4,5-dihydro-4-tert-butyloxazole], min. 95%(4S,4'S)-2,2'-Cyclobutylidenebis[4,5-dihydro-4-tert-butyloxazole], min. 95%Ver →
(4S,4'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4-phenyl-4,5-dihydrooxazole), 98%, (99% ee)(4S,4'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4-phenyl-4,5-dihydrooxazole), 98%, (99% ee)Ver →
(4S,4'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4-tert-butyl-4,5-dihydrooxazole), 98%, (99% ee)(4S,4'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4-tert-butyl-4,5-dihydrooxazole), 98%, (99% ee)Ver →
(4S,4'S)-2,2'-Cyclohexylidenebis[4-tert-butyl-4,5-dihydrooxazole], 98%, (99% ee)(4S,4'S)-2,2'-Cyclohexylidenebis[4-tert-butyl-4,5-dihydrooxazole], 98%, (99% ee)Ver →
(4S,4'S)-2,2'-Cyclopentylidenebis[4,5-dihydro-4-phenyloxazole], 98%, (99% ee)(4S,4'S)-2,2'-Cyclopentylidenebis[4,5-dihydro-4-phenyloxazole], 98%, (99% ee)Ver →
(4S,4'S)-2,2'-Cyclopentylidenebis[4-tert-butyl-4,5-dihydrooxazole], 95%, (99% ee)(4S,4'S)-2,2'-Cyclopentylidenebis[4-tert-butyl-4,5-dihydrooxazole], 95%, (99% ee)Ver →
(4S,4'S)-2,2'-Cyclopropylidenebis[4-tert-butyl-4,5-dihydrooxazole], 95%(4S,4'S)-2,2'-Cyclopropylidenebis[4-tert-butyl-4,5-dihydrooxazole], 95%Ver →
(4S,4'S,5R,5'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4,5-diphenyloxazole], min. 98%(4S,4'S,5R,5'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4,5-diphenyloxazole], min. 98%Ver →
(4S,4'S,5R,5'R)-2,2'-(Cycloheptane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole), 95%, (99% ee)(4S,4'S,5R,5'R)-2,2'-(Cycloheptane-1,1-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole), 95%, (99% ee)Ver →
(4S,4'S,5R,5'R)-2,2'-Cyclohexylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%, (99% ee)(4S,4'S,5R,5'R)-2,2'-Cyclohexylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%, (99% ee)Ver →
(4S,4'S,5R,5'R)-2,2'-Cyclopropylidenebis[4,5-dihydro-4,5-diphenyloxazole], 95%, (99% ee)(4S,4'S,5R,5'R)-2,2'-Cyclopropylidenebis[4,5-dihydro-4,5-diphenyloxazole], 95%, (99% ee)Ver →
(4S,5R)-(-)-4-Benzyl-5-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-2-oxazolidinone, 99%(4S,5R)-(-)-4-Benzyl-5-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-2-oxazolidinone, 99%Ver →
(4S,5R)-(-)-4-i-Propyl-5-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-2-oxazolidinone, 99%(4S,5R)-(-)-4-i-Propyl-5-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-2-oxazolidinone, 99%Ver →
(4S,5S)-N-(3,5-Bis(trifluoromethyl)phenyl)-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-amine, 98%, (99% ee)(4S,5S)-N-(3,5-Bis(trifluoromethyl)phenyl)-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-amine, 98%, (99% ee)Ver →
((4S,5S)-(-)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydro­oxazol-4-yl)-2-phenyl­ethyl]-dicyclohexyl­phosphinite)(1,5-COD)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenylborate, min. 97% (S,S)-[COD]Ir[cy₂PThrePHOX]((4S,5S)-(-)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydro­oxazol-4-yl)-2-phenyl­ethyl]-dicyclohexyl­phosphinite)(1,5-COD)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenylborate, min. 97% (S,S)-[COD]Ir[cy₂PThrePHOX]Ver →
((4S,5S)-(-)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl]-diphenylphosphinite)(1,5-COD)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenyl­borate, min. 97% (S,S)-[COD]Ir[Ph₂PThrePHOX]((4S,5S)-(-)-O-[1-Benzyl-1-(5-methyl-2-phenyl-4,5-dihydrooxazol-4-yl)-2-phenylethyl]-diphenylphosphinite)(1,5-COD)iridium(I) tetrakis(3,5-bis(trifluoromethyl)phenyl­borate, min. 97% (S,S)-[COD]Ir[Ph₂PThrePHOX]Ver →